Latest Kidney Cancer News

Transcriptomic characterization and innovative molecular classification of clear cell renal cell carcinoma in the Chinese population

Prognostic role of smoking in metastatic renal cell carcinoma in real-world data from the Turkish Oncology Group Kidney Cancer Consortium (TKCC) – Scientific Reports

Thermal Ablation vs Surgery for Stage T1a RCC Offers Similar Cancer-Specific Survival – Oncology Nurse Advisor
Kidney Cancer News elsewhere on the Web

Petryshak et al developed and validated BMVision, an artificial intelligence tool designed to assist radiologists in diagnosing kidney cancer from CT scans. In a reader study with six radiologists, the tool reduces reporting time by 32%, improves detection of benign lesions, and increases ...

Purpose Fumarate hydratase (FH)-deficient renal cell carcinoma (RCC) is a rare and aggressive RCC subtype defined in the 2022 WHO classification. This study aimed to describe its imaging and clinicopathological features. Methods A retrospective analysis was conducted on 11 patients (12 ...

... 2 KEYMAKER-U03 trial tested novel pembrolizumab-based triplet regimens for first-line treatment of advanced clear cell renal cell carcinoma (ccRCC).

“We identified a myeloid mimicry pathway that can drive tumor hyper progression following immunotherapy in renal medullary carcinoma. Inhibiting this ...

Subcutaneous nivolumab was noninferior to intravenous nivolumab for the treatment of advanced or metastatic clear cell renal cell carcinoma (ccRCC), ...

Rare subtypes of renal cancers can be difficult to diagnose. Here, the authors use transcriptional analysis to show utility in aiding histological classification.

Kidney renal cell carcinoma (RCC) is a highly invasive malignancy, where early-stage diagnosis can significantly reduce treatment complexity and mortality risk. This study aims to enhance diagnostic precision through a novel model, RCC-ProbNet, capable of identifying and classifying RCC across ...

In recent years, the search for robust biomarkers to guide treatment and predict outcomes in cancer has taken on new urgency, especially in the context of clear cell renal cell carcinoma (ccRCC). This

For patients with renal cell carcinoma (RCC), receiving adjuvant durvalumab with tremelimumab after nephrectomy improves disease-free survival ...

ccRCC is an aggressive, heterogeneous tumor with a poor prognosis. Prognostic assessments need multi-modal data. Radiological images have limits, while pathological images offer micro-level details. Integrating these for ccRCC outcome prediction is important. Our study aimed to develop and ...
No results found.
Articles from Kidney Cancer UK
No results found.
No results found.





